Identification of cortactin molecular forms in human urine and their possible diagnostic value

The protein composition of human urine reflects changes in the biochemical and physiological status of an individual and has an essential diagnostic value. Using precipitation/extraction methods we isolated a protein with Mr ~100 kDa in a human urine. MALDI TOF/TOF mass spectrometry identified this...

Full description

Bibliographic Details
Published in:	The Ukrainian Biochemical Journal
Main Authors:	M. Starykovych, S. Souchelnytskyi, O. Fayura, O. Abrahamovych, M. Abrahamovych, N. Lukavetskyy, R. Stoika, Y. Kit
Format:	Article
Language:	English
Published:	National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2021-08-01
Subjects:	cortactins human urine liver cirrhosis lung cancer
Online Access:	http://ukrbiochemjournal.org/wp-content/uploads/2021/09/Starykovych_4_21.pdf

Similar Items

Spectrum of Cortactin Isoforms in the Urine of Patients with Liver Cirrhosis and Their Diagnostic Value as a Potential Molecular Marker of its Severity
by: Fayura O., et al.
Published: (2019-10-01)

Severity Degrees of Syntropic Stable Arterial Hypotension in the Cirrhotic Patients and Their Dependence on the Daily Blood Pressure Monitoring and Liver Damage Class by C.G. Child – R.N. Pugh
by: Abrahamovych M., et al.
Published: (2018-09-01)

Redox Homeostasis Index as a Criterion for Differentiated Inclusion of Antioxidants in Complex Treatment of the Patients with Liver Cirrhosis of Different Severity Degrees and Evaluation of Its Effectiveness
by: O. Fayura, et al.
Published: (2020-06-01)

Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility
by: Wang Wenqi, et al.
Published: (2011-11-01)

State of the Autonomic Nervous System in Patients with the Different Severity Stages of Cirrhosis of the Liver
by: Abrahamovych O., et al.
Published: (2014-12-01)

A collaborative immunohistochemical study of Drp1 and cortactin in the epithelial dysplasia and oral squamous cell carcinoma
by: Marina Nader, et al.
Published: (2025-04-01)

REDOX-HOMEOSTASIS FEATURES IN PATIENTS WITH LIVER CIRRHOSIS DEPENDING ON SEVERITY OF THE INTERNAL ORGANS SYNTROPIC COMORBID LESIONS
by: M. O. Abrahamovych, et al.
Published: (2020-03-01)

Effects of Cortactin Expression on Prognosis in Patients with Breast Cancer
by: Hwangkyu Son, et al.
Published: (2023-09-01)

miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene
by: Yongwen Li, et al.
Published: (2018-07-01)

Nuclear N-WASP Induces Actin Polymerization in the Nucleus with Cortactin as an Essential Factor
by: Xin Jiang, et al.
Published: (2025-01-01)

Cortactin contributes to the tumorigenesis of gastric cancer by activating ERK/MMP pathway
by: Yi Zhao, et al.
Published: (2023-07-01)

Visual Signs of Chronic Diffuse Liver Diseases: the Stigma of Skin, its Appendages and Mucous Membranes
by: Abrahamovych M., et al.
Published: (2013-09-01)

The Сontent of Some Humoral and Metabolic Vasoactive Factors in the Blood of the Cirrhotic Patients and Their Dependence on the Hepatopulmonary Syndrome Severity Degree
by: Abrahamovych M., et al.
Published: (2016-12-01)

Content of Some Endothotelium-Dependent Vasoactive Substances in the Blood of Patients, Depending on the Liver Cirrhosis Severity and the Organism’s Redox System State
by: Abrahamovych M., et al.
Published: (2019-12-01)

Cortactin Contributes to Activity-Dependent Modulation of Spine Actin Dynamics and Spatial Memory Formation
by: Jonas Cornelius, et al.
Published: (2021-07-01)

Cortactin Facilitates Malignant Transformation of Dysplastic Cells in Gastric Cancer DevelopmentSummary
by: Alexis A. Guenther, et al.
Published: (2025-01-01)

The actin binding proteins cortactin and HS1 are dispensable for platelet actin nodule and megakaryocyte podosome formation
by: Steven G. Thomas, et al.
Published: (2017-05-01)

The Actin-Binding Protein Cortactin Promotes Sepsis Severity by Supporting Excessive Neutrophil Infiltration into the Lung
by: Nathaniel L. Lartey, et al.
Published: (2022-04-01)

Cortactin interacts with αDystrobrevin-1 and regulates murine neuromuscular junction morphology
by: Teresa De Cicco, et al.
Published: (2024-06-01)

Molecular Actions of Thyroid Hormone on Breast Cancer Cell Migration and Invasion via Cortactin/N-WASP
by: Ivonne Denise Uzair, et al.
Published: (2019-03-01)

Short-hairpin RNA-mediated suppression of cortactin may inhibit the migration and invasion abilities of endometrial cancer cells by reducing lamellipodia
by: Huisi Lin, et al.
Published: (2023-12-01)

Csk controls leukocyte extravasation via local regulation of Src family kinases and cortactin signaling
by: Rebekka I. Stegmeyer, et al.
Published: (2024-10-01)

Direct observation of cortactin protecting Arp2/3-actin filament branch junctions from GMF-mediated destabilization
by: Emma R. McGuirk, et al.
Published: (2024-03-01)

Cortactin-dependent control of Par1b-regulated epithelial cell polarity in Helicobacter infection
by: Irshad Sharafutdinov, et al.
Published: (2024-06-01)

Substantiation of Principles and Effectiveness of Advanced Complex Differentiated Treatment of Circulatory System Organs Affections in Patients With Liver Cirrhosis
by: Farmaha M., et al.
Published: (2019-12-01)

Characteristics and Features of the Circulatory System Status in Patients with Liver Cirrhosis as a Disease of Multiple Organ Lesions: Pathogenesis; Diagnostics; Principles of their Treatment (Literature Review and Clinical Case Description)
by: Farmaha M., et al.
Published: (2017-09-01)

Modified Сomplex Treatment of the Cirhotic Patients with the Hepatopulmonary Syndrome of the Different Severity Degrees: Pathogenetic Reasoning and Efficiency
by: Abrahamovych M., et al.
Published: (2017-03-01)

Clinical Markers of the Syntropic Comorbid Lesions of the Circulatory System in Patients with Liver Cirrhosis
by: Abrahamovych M., et al.
Published: (2018-06-01)

Treatment of the Liver Cirrhosis: Modern Principles, Considering Syntropic Co- and Multimorbid Lesions of other Organs and Systems of Organs
by: Abrahamovych M., et al.
Published: (2013-06-01)

Cortactin Promotes Effective AGS Cell Scattering by <i>Helicobacter pylori</i> CagA, but Not Cellular Vacuolization and Apoptosis Induced by the Vacuolating Cytotoxin VacA
by: Irshad Sharafutdinov, et al.
Published: (2021-12-01)

The Modern View on the Problem of Respiratory Lesions in Patients with Liver Cirrhosis. Clinical Case Description
by: Abrahamovych M., et al.
Published: (2016-07-01)

State Acid-Base Balance in Patients with Liver Cirrhosis: Role in the Pathogenesis of Respiratory Lesions; Dependence on the Degree of Liver Damage
by: Abrahamovych M., et al.
Published: (2015-12-01)

Charcteristics of the Autonomic Nervous System in Patients with Liver Cirrhosis and its Dependence on the Severity of Portal Hypertension due to the Values of the Heart Rate Variability Parameters
by: Abrahamovych M., et al.
Published: (2016-07-01)

Characteristics of Syntropie Comorbid Extrahepatic Lesions in Patients with Liver Cirrhosis Depending on the Portal Hypertension Severity Degree
by: Abrahamovych M., et al.
Published: (2016-09-01)

Peculiarities of Calcium-Phosphorus Metabolism and Bone State in Patients with Liver Cirrhosis: Diagnosis and Principles of Differential Treatment (Literature Rewiev and Clinical Case Description)
by: Drobinska N., et al.
Published: (2018-06-01)

Oxidative stress as one of the pathogenetic mechanisms of hepatopulmonary syndrome in patients with liver cirrhosis
by: O.P. Faiura, et al.
Published: (2024-03-01)

AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility
by: Mohamed Zardab, et al.
Published: (2025-01-01)

Comorbidity: a Modern View on the Problem; Classification (first notice)
by: Abrahamovych O., et al.
Published: (2015-12-01)

Comorbidity: a Modern View on the Problem; Classification (second notice)
by: Abrahamovych O., et al.
Published: (2016-07-01)

TORCH-Infection and Its Possible Role in Syntropic Liver Damage in Patients with Systemic Lupus Erythematosus (literature review and clinical case description)
by: Abrahamovych U., et al.
Published: (2013-12-01)